The Drug Release of PLGA-based Nanoparticles and Their Application in Treatment of Gastrointestinal Cancers

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Oct 4

PMID 39364250

Authors

Rui Sun

Yanfei Chen

Yanjiang Pei

Wenbin Wang

Zhi Zhu

Zhaohua Zheng

Limeng Yang

Li Sun

Affiliations

Soon will be listed here.

Abstract

The poly (lactic-co-glycolic acid) (PLGA) based nanoparticles have been applied for drug delivery due to their simple preparation, biodegradability, and ideal biocompatibility. In this study, the factors affecting the degradation of PLGA-based nanoparticles are reviewed, encompassing the ratio of PLA to PGA, relative molecular weight, crystallinity, and preparation process of PLGA nanoparticles. The drug release behavior of PLGA-based nanoparticles, such as the degradation environment, encapsulated drug properties of polymers, and drug loading rates, are also discussed. Since gastrointestinal cancer is one of the major global threats to human health, this paper comprehensively summarizes the application of PLGA nanoparticles in gastrointestinal cancers from diagnosis, chemotherapy, radiotherapy, and novel tumor treatment methods (immunotherapy, gene therapy, and photothermal therapy). Finally, the future application of PLGA-based drug delivery systems in treating gastrointestinal cancers is discussed. The bottleneck of application status and the prospect of PLGA-nanoparticles in gastrointestinal tumor application are presented. To truly realize the great and wide application of PLGA-based nanoparticles, collaborative progress in the field of nanomaterials and life sciences is needed.

Citing Articles

Polymers for the treatment of Alzheimer's disease.

Zhu Y, Xu H, Yu C, Jiang W, Hou X, Ma M Front Pharmacol. 2025; 16:1512941.

PMID: 39944627 PMC: 11813879. DOI: 10.3389/fphar.2025.1512941.

Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases.

Parvin N, Joo S, Mandal T J Funct Biomater. 2025; 16(1).

PMID: 39852580 PMC: 11766201. DOI: 10.3390/jfb16010024.

Maytansinoids in cancer therapy: advancements in antibody-drug conjugates and nanotechnology-enhanced drug delivery systems.

Perra M, Castangia I, Aroffu M, Fulgheri F, Abi-Rached R, Manca M Discov Oncol. 2025; 16(1):73.

PMID: 39838217 PMC: 11751265. DOI: 10.1007/s12672-025-01820-z.

Comparison of Drug Delivery Systems with Different Types of Nanoparticles in Terms of Cellular Uptake and Responses in Human Endothelial Cells, Pericytes, and Astrocytes.

Sahin H, Yucel O, Holloway P, Yildirim E, Emik S, Gurdag G Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770409 PMC: 11679882. DOI: 10.3390/ph17121567.

References

Yang Y, Zhang J, Xia F, Zhang C, Qian Q, Zhi X . Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy. Nanoscale Res Lett. 2016; 11(1):285. PMC: 4894853. DOI: 10.1186/s11671-016-1468-8. View

Zhang Z, Wang L, Ding Y, Wu J, Hu Y, Yuan A . Synergy of hypoxia relief and chromatin remodeling to overcome tumor radiation resistance. Biomater Sci. 2020; 8(17):4739-4749. DOI: 10.1039/d0bm00119h. View

Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M . Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007; 109(9):3812-9. DOI: 10.1182/blood-2006-07-035972. View

Ajani J, Takiuchi H . Recent developments in oral chemotherapy options for gastric carcinoma. Drugs. 2000; 58 Suppl 3:85-90. DOI: 10.2165/00003495-199958003-00012. View

Liu Y, Bhattarai P, Dai Z, Chen X . Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2018; 48(7):2053-2108. PMC: 6437026. DOI: 10.1039/c8cs00618k. View

Li Y, Seto E . HDACs and HDAC Inhibitors in Cancer Development and Therapy. Cold Spring Harb Perspect Med. 2016; 6(10). PMC: 5046688. DOI: 10.1101/cshperspect.a026831. View

Barberio M, Pizzicannella M, Spota A, Ashoka A, Agnus V, Al Taher M . Preoperative endoscopic marking of the gastrointestinal tract using fluorescence imaging: submucosal indocyanine green tattooing versus a novel fluorescent over-the-scope clip in a survival experimental study. Surg Endosc. 2020; 35(9):5115-5123. PMC: 8346416. DOI: 10.1007/s00464-020-07999-2. View

Frank A, Rath S, Venkatraman S . Controlled release from bioerodible polymers: effect of drug type and polymer composition. J Control Release. 2005; 102(2):333-44. DOI: 10.1016/j.jconrel.2004.10.019. View

Clement S, Anwer A, Pires L, Campbell J, Wilson B, Goldys E . Radiodynamic Therapy Using TAT Peptide-Targeted Verteporfin-Encapsulated PLGA Nanoparticles. Int J Mol Sci. 2021; 22(12). PMC: 8232618. DOI: 10.3390/ijms22126425. View

10.

LaVan D, McGuire T, Langer R . Small-scale systems for in vivo drug delivery. Nat Biotechnol. 2003; 21(10):1184-91. DOI: 10.1038/nbt876. View

11.

Alsaab H, Alharbi F, Alhibs A, Alanazi N, Alshehri B, Saleh M . PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases. Pharmaceutics. 2022; 14(12). PMC: 9786338. DOI: 10.3390/pharmaceutics14122728. View

12.

Ji T, Kohane D . Nanoscale systems for local drug delivery. Nano Today. 2020; 28. PMC: 7442295. DOI: 10.1016/j.nantod.2019.100765. View

13.

Ibarra J, Encinas-Basurto D, Almada M, Juarez J, Valdez M, Barbosa S . Gold Half-Shell-Coated Paclitaxel-Loaded PLGA Nanoparticles for the Targeted Chemo-Photothermal Treatment of Cancer. Micromachines (Basel). 2023; 14(7). PMC: 10384528. DOI: 10.3390/mi14071390. View

14.

Shakeri-Zadeh A, Khoee S, Shiran M, Sharifi A, Khoei S . Synergistic effects of magnetic drug targeting using a newly developed nanocapsule and tumor irradiation by ultrasound on CT26 tumors in BALB/c mice. J Mater Chem B. 2020; 3(9):1879-1887. DOI: 10.1039/c4tb01708k. View

15.

Korade Z, Folkes O, Harrison F . Behavioral and serotonergic response changes in the Dhcr7-HET mouse model of Smith-Lemli-Opitz syndrome. Pharmacol Biochem Behav. 2013; 106:101-8. DOI: 10.1016/j.pbb.2013.03.007. View

16.

Qu Y, Chen L, Lowe D, Storkus W, Taylor J . Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo. Mol Ther. 2012; 20(3):644-51. PMC: 3293621. DOI: 10.1038/mt.2011.283. View

17.

Schleich N, Sibret P, Danhier P, Ucakar B, Laurent S, Muller R . Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. Int J Pharm. 2013; 447(1-2):94-101. DOI: 10.1016/j.ijpharm.2013.02.042. View

18.

Xu L, Sheflin L, Porter N, Fliesler S . 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Biochim Biophys Acta. 2012; 1821(6):877-83. PMC: 3340457. DOI: 10.1016/j.bbalip.2012.03.001. View

19.

Essa D, Kondiah P, Choonara Y, Pillay V . The Design of Poly(lactide-co-glycolide) Nanocarriers for Medical Applications. Front Bioeng Biotechnol. 2020; 8:48. PMC: 7026499. DOI: 10.3389/fbioe.2020.00048. View

20.

Hu L, Cao Z, Ma L, Liu Z, Liao G, Wang J . The potentiated checkpoint blockade immunotherapy by ROS-responsive nanocarrier-mediated cascade chemo-photodynamic therapy. Biomaterials. 2019; 223:119469. DOI: 10.1016/j.biomaterials.2019.119469. View